Jason A. Femrite

Mergers and Acquisitions

• Represented majority shareholders of healthy snack company in its $340M sale to an international food brand.
• Represented a manufactured products company in its $100M sale to an international leading competitor.
• Represented a manufacturing company in its $150M sale to a leading international conglomerate.
• Represented a leading manufacturer of equipment in its $75M sale to a strategic buyer.
• Represented a leading logistics company in its $50M sale to a financial buyer.
• Represented behavioral health company in its $33M sale to a leading private equity construction firm.
• Represented Nasdaq software simulation company in its acquisitions of a French software solution company, a clinical trial data analysis company, and a drug –induced liver analysis company collectively valued at over $30M.
• Represented online skateboard retailer in its sale to a private equity fund.
• Represented online retailer of baby products in its sale to a private equity fund.
• Represented agricultural supply company in its sale to an international private equity backed company for more than $50M.
• Represented provider of electric utility billing & data management services, energy portfolio management, and energy procurement strategies in its sale to a leading private equity firm.
• Represented the largest privately held nursing company in its $40M acquisition of a national provider of healthcare workforce solutions.
• Represented consumer products manufacturer in its $30M sale to a large, private equity-backed, strategic buyer.
• Represented manufacturer of custom cable solutions in its $25M sale to a global strategic buyer.
• Represented majority owner of a real estate development and management platform in its sale to a strategic buyer for $23M.
• Represented owners of regional food and beverage franchise chain in a $30M sale to a large private equity fund.
• Represented private equity sponsor in its majority acquisition of a pet food company.
• Represented medical supply company in its $160M sale to a leading healthcare private equity firm.
• Represented behavioral health company in its $33M sale to a leading private equity construction firm.
• Represented leasing platform housing company in its $250M sale to a leading Nasdaq provider of real estate software and data analytics company.
• Represented golf simulation company in its $30M sale to a private equity firm and golf manufacturing company.
• Represented Nasdaq software simulation company in its acquisition of a clinical trial data analysis company and a drug –induced liver analysis company valued at over $15M.
• Represented Irish pharmaceutical company in $2.5B merger with a NASDAQ pharmaceutical company.
• Represented management in their $165M buyout of the US operations of a large London Stock Exchange homebuilder, which included a separately negotiated $60M private financing component.
• Represented medical device manufacturer in its $30M sale to German acquirer.
• Represented transportation company in its $27M acquisition by a private equity fund.
• Represented NYSE company in acquisition of 50 cash advance companies in Southern California.
• Represented Italian biotech company in significant licensing/stock deal with NASDAQ biopharma company.
• Represented large privately held international life-sciences company in connection with the $95M sale of its, and its subsidiaries, outstanding capital stock to a global provider of biological products and enabling technologies listed on the NASDAQ national stock market.
• Represented a large state pension fund in connection with the disposition of its approximately $70M investment in two international real estate funds.
• Represented a subsidiary of a large publicly-traded homebuilder in connection with the approximately $48M acquisition of all of the outstanding equity of a local developer.
• Represented a leading wholesale distributor in connection with strategic acquisitions totaling more than $45M.
• Represented large privately held foreign corporation in connection with its $30M acquisition of US-based software company.
• Represented Internet-based information technology company in connection with its $30M acquisition by a large strategic partner.
• Represented manufacturer of telecommunications equipment in connection with the approximately $25M acquisition of all of its outstanding equity to the US subsidiary of a large international conglomerate.
• Represented manufacturer in aerospace industry in connection with the sale of all of its outstanding equity for approximately $20M to a private equity fund.

Financings

• Represented high end hunting gear company in its $50M sale of minority interest to leading private consumer growth equity firm.
• Represented leading alternative creamer in its Series B Preferred round led by large private equity fund.
• Represented leading beverage company in its Series D Preferred round led by large private equity fund.
• Represented Irish biotechnology company in $87M secondary public offering of shares in a NASDAQ biopharmaceutical company.
• Represented one of a group of investors in connection with the $500M financing of a production company.
• Represented a pharmaceutical company listed on NASDAQ in connection with $45M of PIPE financings.
• Represented a private company providing tools to foster safer driving and to aid in crash reconstruction in connection with an offering of Series D Preferred Stock to investors for approximately $41M.
• Represented one of a group of investors in connection with the $40.5M financing of an AMEX listed pharmaceutical company.
• Represented underwriter in connection with a $15M firmly underwritten public offering.
• Represented provider of interactive digital broadband services in connection with $15M financing by several institutional investors led by NYSE listed company.